Loading stock data…
SLP
$14.91+0.74 (+5.22%)
Market ClosedLast close May 1
Simulations Plus, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Simulations Plus, Inc. in the Healthcare sector is trading at $14.91. The stock is currently near its 52-week low of $11.09, remaining 2.9% below its 200-day moving average. Technical signals show neutral RSI of 64 and bullish MACD crossover, explaining why SLP maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 64) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$14.91
Potential Upside
5%
Whystock Fair Value$15.66
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Buy
Mean target$23.67+58.7%
Range$16.00 – $31.00
Fundamentals
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Softwar...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$290.86M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-49.39%
Volume
Today's trading volume
175,398
Recent News
Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips
BMI misses Q1 estimates as sales fall 9% on project delays, but a strong pipeline and UDlive acquisition signal confidence in long-term growth.
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development
Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced collaboration programs for AI-enabled modeling in drug development. Simulations Plus uses AI to help scientists increase efficiency in their modeling workflow. The company said three large pharmaceutical companies were participating in its collaboration programs. Back […]
How The Sylvania Platinum (AIM:SLP) Story Is Shifting As Valuation Tweaks Meet New Guidance
Sylvania Platinum’s fair value price target has shifted from £1.67 to £1.65, a small adjustment that still matters if you are tracking where analysts think the shares should sit. Recent Street research links these moves to a series of fine tuned changes in their views, with earlier 3 GBp upward adjustments now followed by a more cautious 1 GBp cut. As you read on, you will see how these evolving targets shape the broader narrative you can use to frame your own view on the stock. Analyst Price...
Simulations Plus Q2 Earnings Call Highlights
Simulations Plus (NASDAQ:SLP) reported second-quarter fiscal 2026 revenue of $24.3 million, exceeding the top-line guidance management provided last quarter, as the company delivered growth in both its software and services segments. Chief Executive Officer Sean O’Connor said adjusted EBITDA was $8.
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid
Stock futures are essentially flat, reflecting a market waiting for confirmation. Markets are ending the week in a cautious holding pattern, with momentum from earlier in the week fading. Claim 30% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Oil is creeping higher again, hovering near the $100 per barrel level, as doubts grow around t